Editorial: Impact of the Covid-19 pandemic and lung transplantation program in France.

C.Picarda J.Le PavecbA.TissotcGroupe Transplantation Pulmonaire de la Société de Pneumologie de Langue Française SPLF Respiratory Medicine and Research Volume 78, 2020, . 100758 https://doi.org/10.1016/j.resmer.2020.100758 Full text at : https://www.sciencedirect.com/science/article/pii/S2590041220300131?via%3Dihub

Extract: Severe acute respiratory syndrome coronavirus 2 infection is causing the ongoing Covid-19 pandemic, which has already killed thousands of people worldwide, especially older patients who have cardiovascular risk factors and live in large cities [1]. As in most countries, the French government has ordered confinement of the population (decree n° 2020-260 of March 16th). People can leave home only for vital daily activities, such as purchasing food, medical appointments, and work in sectors essential to survival of the population. Three weeks after, the impact on lung transplantation (LT) programs is already major.

The first consequence is that lung transplantation is no longer feasible. Usually 11 LT teams (including 2 paediatric teams) perform 350 to 400 LTs per year in France. Between March 17th and April 7th, 2019, the CRISTAL registry, which monitors transplantation activities in France (Agence de la Biomédecine) recorded 24 routine and 7 high emergency (HE) LT [2], compared to 0 and 2, respectively, during the same period in 2020. During the same three week period, lung donations declined from 120 in 2019 to 53 in 2020.